Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?
-
- Breland Smith
- Department of Chemistry & Biochemistry, the University of Arizona, Tucson, Arizona 85721, United States
-
- Federico Medda
- BIO5 Oro Valley, the University of Arizona, 1580 East Hanley Boulevard, Oro Valley, Arizona 85737, United States
-
- Vijay Gokhale
- Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States
-
- Travis Dunckley
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona 85013, United States
-
- Christopher Hulme
- Department of Chemistry & Biochemistry, the University of Arizona, Tucson, Arizona 85721, United States
収録刊行物
-
- ACS Chemical Neuroscience
-
ACS Chemical Neuroscience 3 (11), 857-872, 2012-09-07
American Chemical Society (ACS)
